Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey
Objective
Increased serum phosphate is associated with adverse health outcomes. High intake of inexpensive processed and fast foods is common in impoverished communities, and is linked with excessive dietary phosphorus intake and elevated serum phosphate concentrations in chronic kidney disease patients. We examined the impact of socioeconomic status on dietary phosphorus intake and serum phosphate concentrations in the general population.
Design
Cross-sectional study.
Participants
A total of 14,261 adult participants in the Third National Health and Nutrition Examination Survey.
Predictors and Outcomes
Poverty to income ratio (PIR; family income indexed to the federal poverty level) was the primary index of socioeconomic status. Serum phosphate was the primary outcome variable.
Results
Although estimated phosphorus intake decreased with decreasing quartiles of PIR (P < .001), serum phosphate was inversely associated with PIR (P = .003). The relationship between lower PIR and higher serum phosphate remained significant after adjustment for demographic, laboratory, and dietary intake characteristics (P = .02). Compared with participants in the highest PIR quartile (income >300% of the federal poverty level), participants in the lowest quartile (income < the federal poverty level) had more than twice the odds of hyperphosphatemia (≥4.4 mg/dL) in unadjusted and multivariable-adjusted logistic regression analyses (OR, 2.2; 95% CI, 1.5 to 3.2).
Conclusions
Although lower income was associated with decreased estimated phosphorus intake, increasing poverty was independently linked with increased serum phosphate and higher likelihood of hyperphosphatemia. These findings may indicate that conventional dietary instruments underestimate phosphorus intake, especially among impoverished individuals. Further studies are needed to explore these possibilities.
This study was supported by the American Kidney Fund Clinical Scientist in Nephrology Fellowship (to Dr. Isakova) and grants K23DK081673 (to Dr. Gutiérrez), R01DK076116 and R01DK081374 (to Dr. Wolf) from the National Institutes of Health.
Dr. Gutiérrez reports accepting speaking honoraria from Abbott. Dr. Isakova reports receiving honoraria from Shire. Dr. Wolf reports receiving research support from Shire and honoraria from Abbott, Genzyme, Shire, and Davita.
PII: S1051-2276(10)00072-5
doi:10.1053/j.jrn.2010.03.001
© 2011 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.

